Back to search

Article

Pharmacokinetics, safety, and tolerability of a THC:CBD oil formulation in patients with chronic non-cancer pain on long term high dose opioid analgesia.

2021-06-22

Abstract excerpt

<h4>Aim: </h4> This Phase I open label study examined pharmacokinetics, safety, and tolerability of escalating doses of a combination cannabinoid medication (1:1 ratio THC:CBD) in patients with chronic non-cancer pain (CNCP) on high dose opioid analgesia. Methods Nine people with CNCP and oral morphine equivalent daily dose of ≥60mg were recruited. Blood concentrations of THC, 11-hydroxytetrahydrocannabinol (OH-TH...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7d6749e2-404e-5a43-9bc3-85012d1f6246
DOI
10.22541/au.162440611.15063689/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pharmacokinetics, safety, and tolerability of a THC:CBD oil formulation in patients with chronic non-cancer pain on long term high dose opioid analgesia.DOI 10.22541/au.162440611.15063689/v1
Pharmacokinetics and Central Accumulation of Delta-9-Tetrahydrocannabinol (THC) and its Bioactive Metabolites Are Influenced by Route of Administration and SexSemantic proximity
A large Australian longitudinal cohort registry demonstrates sustained safety and efficacy of oral medicinal cannabis for at least two yearsSemantic proximity
Population pharmacokinetics of Δ 9 -tetrahydrocannabinol and an active metabolite in older patients with poor appetiteSemantic proximity
Medicinal Cannabis - Potential Drug InteractionsSemantic proximity
The Mapping of Physiological Conversion Pathways from the Major Acidic CannabinoidsSemantic proximity
Ten-Year Outcomes of Medical Cannabis for Chronic Low Back Pain: Opioid Reduction, Pain Relief, and Functional Improvement in 1,000 PatientsSemantic proximity
Targeting of cannabinoids in hair and androgens in saliva and untargeted profiling of the effects of exerciseSemantic proximity
Exploring Novel Pharmacotherapy Candidates for Cannabis Use Disorder: Uncovering Promising Agents on the Horizon by Mechanism of ActionSemantic proximity
Vapor inhalation of cannabidiol (CBD) in ratsSemantic proximity
Single dose delta-9-tetrahydrocannabinol in chronic pancreatitis patients: analgesic efficacy, pharmacokinetics and tolerability.Semantic proximity
Use of CBD - Medicinal CannabisSemantic proximity
Evidence for adverse effects of cannabidiol (CBD) products and their non-conformity on the European food market – response to the European Industrial Hemp AssociationSemantic proximity
Select a neighboring publication to make it the new centre.